Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
8
89%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(3)
Other(1)

Detailed Status

Recruiting4
Completed3
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

recruiting444%
not_yet_recruiting111%
unknown111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9